Single photon emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement

Rheumatology

Volumn 47, Issue 3, 2008, Pages 319-323

  Castellino, Gabriela ^a   Padovan, M ^a   Bortoluzzi, A ^a   Borrelli, M ^b   Feggi, L ^b   Caniatti, M L ^b   Trotta, F ^a   Govoni, M ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b S ANNA HOSPITAL   (Italy)

Author keywords

Central nervous system; Magnetic resonance imaging; Single photon emission computed tomography; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HYDROXYCHLOROQUINE; PREDNISOLONE;

ADULT; ARTICLE; BOLUS INJECTION; BRAIN DISEASE; BRAIN PERFUSION; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG RESPONSE; FEMALE; FRONTAL LOBE; HEMISPHERE; HUMAN; IMAGE ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; WHITE MATTER;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 39449130485     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem354     Document Type: Article

References (22)

1. McCune WJ, Golbus J. Neuropsychiatric lupus. Rheum Dis Clin North Am 1988;14:149-67.
2. ACR ad hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology. Arthritis Rheum 1999;42:599-608.
3. Govoni M, Castellino G, Padovan M, Borrelli M, Trotta F. Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus. Lupus 2004;13:149-58.
4. Bosma GP, Steens SCA, Petropoulos H et al. Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2004;50:3195-202.
5. Jennings JE, Sundgren PC, Attwood J, McCune J, Maly P. Value of MRI ofthe brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology 2004;46:15-21.
6. Sibbitt WL, Schmidt PJ, Hart BL, Brooks WM. Fluid attenuated inversion recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus. J Rheumatol 2003;30:1983-9.
7. Huizinga TWJ, Steens SCA, van Buchem MA. Imaging modalities in central nervous system systemicjupus erythernatDsus. Curr Opinion Rheumatol 2001;13:383-8.
8. Abreu MR, Jakosky A, Folgerini M, Brenol JCT, Xavier RM, Kapczinsky F. Neuropsychiatric systemic lupus erythematosus. Correlation of brain MR imaging, CT, and SPECT. J Clin Imag 2005;29:215-21.
9. Rubbert A, Marienhagen J, Pirner K et al. Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum 1993;36:1253-62.
10. Zhang X, Zhu Z, Zhang F, Shu H, Li F, Dong Y. Diagnostic value of single-photon-emission computed tomography in severe Central nervous system involvement of systemic lupus erythematosus: A case-control study. Arthritis Rheum 2005;53:845-9.
11. Hochberg MC. American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 1997;40:1725.
12. Chang CP, Shiau YC, Wang JJ, Ho ST, Kao A. Abnormal regional cerebral blood flow on 99mTcECD brain SPECT in patients with primary Sjogren's syndrome and normal findings on brain magnetic resonance imaging. Ann Rheum Dis 2002;61:774-8.
13. Colamussi P, Trotta F, Ricci R et al. Brain perfusion SPECT and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations. Nucl Med Commun 1997;18:269-73.
14. Tatum OT, Alavi A, Stecker M. Technetium-99m-HMPAO SPECT in partial status epilepticus. J Nucl Med 1994;35:1087-96.
15. Csepany T, Bereczki D, Kollar J, Sikula J, Kiss E, Csiba L. MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension. J Neurol 2003;250:1348-54.
16. Oku K, Atsumi T, Furukawa S et al. Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement. Rheumatology 2003;42:773-7.
17. Wes SG, Emlen W, Werner MH. Neuropsychiatric lupus erythematosus: A ten year prospective study on the value of diagnostic tests. Am J Med 1995;99:153-W.
18. Bell CL, Pentington C, Robbins M, Turski P, Karnguth S. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titer. Arthritis Rheum 1991:34:432-41.
19. Waterloo K, Omdal R, Sjoholm H et al. Neuropsychological dysfunction 14 systemic lupus erythematosus is not associated with changes in cerebral blood flow. Neurology 2001;248:595-602.
20. Castellino G, Govoni M, Padovan M, Colamussi P, Borrelli M, Trotta. F. Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: A functional multi-imaging approach and follow up. Ann Rheum Dis 2005;64:1022-7.
21. Kozora E, West SG, Kotzin BL, Julian L, Porter S, Bigler E. Magnetic resonance abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1998;41:41-7.
22. McCune WJ, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988;31:159-66.